From left: Ms. Kuna Sabapathy, Deputy CEO of Innoquest Pathology; Dr. Thanikachalam Pasupati Meenakshi, Chief Pathologist at Innoquest Pathology and Consultant Pathologist; En. Jenddy Datuk Sanggau, Political Secretary of YB Datuk James Ratib; Dr. Nahulan A/L Thevarajah, Deputy Medical Director of Jesselton Medical Centre; Datuk Dr. Suzain Binti Suhaimi, Senior Medical Officer of Jesselton Medical Centre.
Kota Kinabalu, Malaysia 14 October 2024 – Innoquest Pathology, Malaysia’s only multi-disciplinary clinical laboratory, accredited by both the College of American Pathologists (CAP) and MS ISO 15189, proudly celebrates the launch of Sabah’s first state-of-the-art digital histopathology laboratory at Jesselton Medical Centre. This facility signals a significant advancement in diagnostic healthcare for the region, offering rapid result turnaround from one week to a mere 1-2 working days, with the ability to process over 400 cases monthly.
Pioneering Digital Pathology Integration
Innoquest Pathology leverages cutting-edge digital pathology to enhance diagnostic precision and efficiency. The transformation of tissue samples into high-resolution digital slides allows for comprehensive electronic analyses and easy sharing of data. Utilising whole-slide imaging (WSI), pathologists can scrutinise tissue morphologies remotely and at any time with accuracy akin to traditional microscopy. This integration is bolstered by Innoquest’s 20 seasoned in-house pathologists, ensuring expert evaluation and reliable diagnostics.
Advancing Patient Care
The rapid diagnostic capability of the new laboratory is vital for the timely identification and treatment of serious illnesses like cancer. By delivering swift and precise results, clinicians can make well-informed decisions more quickly, improving patient outcomes and reducing the stress associated with waiting for test results.
Harnessing AI and Telepathology
Leveraging artificial intelligence, Innoquest employs advanced imaging algorithms to enhance diagnostic accuracy by identifying patterns, quantifying critical biomarkers, and detecting abnormalities such as tumors with heightened efficiency. The digital platform also supports telepathology, facilitating remote expert consultations that further decrease diagnostic times. The storage and management of digital images simplifies the tracking of patient history, aiding comparative studies and future research.
Vision for the Future
Dr. Thanikachalam Pasupati Meenakshi, Chief Pathologist at Innoquest, reflected on the post-pandemic impetus: “Digital pathology became essential during COVID-19, highlighting both its potential and necessity. We seized the opportunity to extend these solutions to East Malaysia, overcoming challenges that have long hindered access to quality healthcare”
Echoing this vision, Ms. Kuna Sabapathy, Deputy CEO of East Malaysia, emphasized, “As Malaysia’s leading independent clinical diagnostics laboratory, Innoquest remains committed to investing in cutting-edge technology and strengthening ties with healthcare institutions to further develop healthcare systems.”
This landmark initiative not only elevates the capabilities of Jesselton Medical Centre but also underscores Innoquest’s mission to deliver exceptional medical services to Sabah, enhancing the reliability and accessibility of advanced healthcare for the community.
END
About Innoquest Pathology
Innoquest Pathology, born from the merger of Clinipath, Quantum, and Gribbles, is the largest private provider of diagnostic laboratory services in the country. Since our inception in 1996, we have grown to operate over 85 electronically-linked pathology facilities throughout Peninsular Malaysia, Sabah, and Sarawak. Headquartered in Petaling Jaya, we employ over 1,200 staff nationwide, performing over 4 million patient episodes per year. Supported by a deep bench of industry expertise and groundbreaking technology, Innoquest proudly serves clinicians, hospitals, medical centres, and their patients with advanced diagnostic testing methods. Our network offers a wide range of in-vitro diagnostic tests to help detect diseases and monitor health. As the only multidisciplinary clinical laboratory in Malaysia with dual accreditation from the College of American Pathologists (CAP) and MS ISO15189, we maintain best-in-class standards, services, and laboratory practices, aiming to strengthen our global presence as a centre of excellence in testing. . For more information, visit https://innoquest.com.my . Follow our updates on LinkedIn , Facebook.
About Jesselton Medical Centre
Jesselton Medical Centre (JMC), a leading provider of healthcare in Kota Kinabalu, offers high-quality, affordable medical care across various specializations. Established in 2009, JMC recently expanded its services to include genetic screening, alongside existing services like cardiology, obstetrics & gynaecology, and pediatrics. The state-of-the-art equipment upgrades in cardiology and nephrology allow for comprehensive non-invasive and invasive procedures, while the new genetic screening empowers individuals with proactive health information. JMC remains committed to exceptional patient care through excellence, compassion, and innovation. Located 4.1 km from the city center, JMC boasts a self-contained facility with 29 consultation rooms, 80 patient beds including ICU and maternity suites. For more information, visit https://jmc.my, and follow their Facebook for updates.
For media enquiries and editorial:
1) Innoquest Pathology
Kuna Sabapathy
Deputy CEO
kuna@innoquest.com.my
+60122384351
2) Jesselton Medical Centre
Celestina Kwan
Acting Chief Operating Officer
admin@jmc.my
+60103687300